Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

IDRA 1.64 -0.04 (-2.67%)
price chart
Idera Pharmaceuticals Inc. (IDRA) Drops 10.33% on February 08
Idera Pharmaceuticals Inc. (IDRA) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 10.33% to $1.65, a loss of $-0.19 per share.
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Ready For A Comeback
2015 was a rough year for shareholders of Idera Pharmaceuticals Inc (NASDAQ:IDRA). While the company made considerable progress, shares were on a downtrend for all of 2015.
Zacks: Analysts Set $6.33 Target Price for Idera Pharmaceuticals Inc (NASDAQ ...  Financial Market News
Idera Pharmaceuticals Incorporated (NASDAQ:IDRA) Short Interest Increased By 9.78%
The short interest to Idera Pharmaceuticals Incorporated's float is 14.77%. The stock is up 2.08% or $0.04 after the news, hitting $1.72 per share.
Why Idera Pharmaceuticals Inc. Shares Dropped 36% in 2015
What: Shareholders of Idera Pharmaceuticals (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on cancer and other rare diseases, had a rough 2015.
Idera Pharmaceuticals Inc (IDRA) Rating Lowered to Sell at Zacks Investment ...  Zolmax
Biotech Stock in Limelight: Idera Pharmaceuticals Inc  iStreetWire
Why Shares in Idera Pharmaceuticals, Inc. Dropped 10% Today
The company's trailing-12-month operating expenses totaled $48.75 million through September, and the company's balance sheet boasted just $95 million exiting Q3, so there's a good chance Idera Pharmaceuticals will be on the hunt for new funding, which ...
Momentum Rating Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  Enterprise Leader
Why Idera Pharmaceuticals Shares Soared Today
What: After presenting early-stage data in support of its drug for Waldenstrom's macroglobulinemia, Idera Pharmaceuticals (NASDAQ:IDRA) shares cimbed 14.7 earlier today. So what: Idera Pharmaceuticals is a clinical-stage company that is researching ...
Idera Pharma Soars Over Positive Trial Data  24/7 Wall St.
Idera Pharma (IDRA) Announces Presentation of IMO-8400 Phase 1/2 Data in WM ...  StreetInsider.com
Idera Pharmaceuticals Inc. (IDRA) Drops 8.76% on January 18
Idera Pharmaceuticals Inc. (IDRA) was one of the Russell 2000's biggest losers for Monday January 18 as the stock slid 8.76% to $1.98, a loss of $-0.19 per share.
Idera Pharmaceuticals Inc. (IDRA) Drops 9.22% on January 15
Idera Pharmaceuticals Inc. (IDRA) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 9.22% to $1.97, a loss of $-0.2 per share.
Zacks: Brokerages Set $6.33 Price Target for Idera Pharmaceuticals Inc (NASDAQ ...
Idera Pharmaceuticals logo Idera Pharmaceuticals Inc (NASDAQ:IDRA) has earned an average broker rating score of 1.00 (Strong Buy) from the four analysts that provide coverage for the company, Zacks Investment Research reports.
Company Shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Rally 11.49%  WallStreet Prudent
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): Stock in the spotlight  Stocks Daily
Idera Pharmaceuticals Inc. (IDRA) Hits New 52-week Low During January 15 Session
Idera Pharmaceuticals Inc. (IDRA) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $2.12, Idera Pharmaceuticals Inc. dropped to $1.93 for a new 52-week low. By the closing bell, the company's stock ...